Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Items 401–500 of 733
A practical approach to managing diabetes in the perioperative period
du Toit, L., Biesman-Simons, T., Levy, N., & Dave, J. A. (2018) · South African Medical Journal · doi:10.7196/samj.2018.v108i5.13311 · Cited by 7
“Basal-bolus insulin regimen.[16,25,26] (TDD = total daily dose; CBG = capillary blood glucose;”
BackgroundNoninsulin medication therapy for hospitalized patients with diabetes mellitus
Petite, S. E. (2018) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp170869 · Cited by 7
Liu, G. T., Sanders, D., Raspovic, K. M., & Wukich, D. K. (2019) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2019.02.012 · Cited by 6
Ge, V., Subramaniam, A., Banakh, I., Wang, W., & Tiruvoipati, R. (2020) · Journal of Perioperative Practice · doi:10.1177/1750458920948693 · Cited by 7
“Perioperative insulin administration and better glycaemic control (has – deleted) have been shown to improve morbidity (Furnary et al 2003, Umpierrez et al 2011) and should be considered if SGLT2Is are being withheld.”
BackgroundMedical software applications for in-hospital insulin therapy: A systematic review
Lavinas-Jones, J. M., Feitosa, A. C. R., Hita, M. C., Fonseca, E. M., Pato, R. B., & Toyoshima, M. T. K. (2020) · Digital Health · doi:10.1177/2055207620983120 · Cited by 6
Shacham, E. C., Maman, N., & Ishay, A. (2023) · Medicine · doi:10.1097/md.0000000000032650 · Cited by 6
“include basal, prandial, and corrective doses result in better glucose control and fewer complications during hospitalizations.[15] In the last decade, new classes of antidiabetic drugs are increasingly used to improve diabetes control.”
BackgroundUpdate on Inpatient Diabetes Management: Call for Action
Umpierrez, G. E., & Dungan, K. M. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0283 · Cited by 6
Self-citationAmir, M., Sinha, V., Kistangari, G., & Lansang, M. C. (2020) · Endocrine Practice · doi:10.4158/ep-2018-0524 · Cited by 5
Kopanz, J., Mader, J. K., Donsa, K., Libiseller, A., Aberer, F., Pandis, M., Reinisch-Gratzer, J., Ambrosch, G. C., Lackner, B., Truskaller, T., et al. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.986672 · Cited by 5
Liang, L., Liang, L., Huang, Y., Liang, H., Su, J., & Zhou, Y. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07840-6 · Cited by 5
“Nonetheless, a recent interventional study showed a decrease in surgical complications, especially postoperative infections, by achieving good glycemic con-trol during the postoperative period [49].”
Morikawa, L. L., Nery, M., & Toyoshima, M. T. K. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.024 · Cited by 6
Virtual Glucose Management in the Hospital Setting
Rayman, G. A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0590 · Cited by 5
Practical approach to clinical controversies in glycemic control for hospitalized surgical patients
Ware, L. R., Gilmore, J. F., & Szumita, P. M. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10858 · Cited by 5
Leal, J., Wellman, S. S., Jiranek, W. A., Seyler, T. M., Bolognesi, M. P., & Ryan, S. P. (2024) · The Journal of Arthroplasty · doi:10.1016/j.arth.2024.02.069 · Cited by 5
Kanjee, Z., Brown, F. M., Taxin, Z. H., & Smetana, G. W. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-01100 · Cited by 5
Glycemic control in critically ill surgical patients: risks and benefits
May, A. K., Mukherjee, K., Albaugh, V. L., Richards, J. E., & Rumbaugh, K. A. (2015) · Open Access Surgery · doi:10.2147/oas.s50416 · Cited by 5
“111 To date, however, there are no randomized studies evaluating hyperglycemia management and the level of BG control in nondiabetic surgical patients.”
Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus
Karlin, N. J., Cheng, M., Castro, J. C., & Cook, C. B. (2015) · Diabetes Management · doi:10.2217/dmt.15.36 · Cited by 5
Ketz, J. M., Yeh, E. J., & Suri, S. (2019) · Clinical Diabetes · doi:10.2337/cd19-0003 · Cited by 5
“Previous landmark studies (6,7,9) demonstrating the efficacy and safety of basal insulin regimens compared to SSI monotherapy and forming the basis of current inpatient insulin treatment standards excluded patients with ICU stays, surgical procedures, renal failure, hepatic disease, and corticosteroid use.”
BackgroundMethodTiming of Insulin with Meals in the Hospital: a Systems Improvement Approach
Dungan, K. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1232-4 · Cited by 5
Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in the Inpatient Setting
Petite, S. E., & Hill, M. C. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020966150 · Cited by 5
“8 CCI 4 (2-6) 5 (2-7) 4 (2-6) 4 (3-6) 0.”
Hochfellner, D. A., Rainer, R., Ziko, H., Aberer, F., Simic, A., Lichtenegger, K. M., Beck, P., Donsa, K., Pieber, T. R., Fruhwald, F. M., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14458 · Cited by 5
Roberts, G., Chang, L., Park, J. M., & Thynne, T. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110955 · Cited by 5
Gagen, B. R., & Hall, C. M. (2024) · Current Surgery Reports · doi:10.1007/s40137-024-00405-z · Cited by 5
“Control of hyperglycemia with insulin management in the perioperative setting reduces complications, including wound infections, and decreases mortality [46].”
Relationship Between Standardized Glycemic Protocols and Healthcare Cost
Coto, J. A., Yehle, K. S., & Foli, K. J. (2014) · Clinical Nursing Research · doi:10.1177/1054773814539003 · Cited by 7
“Sliding scale insulin (SSI) dosing does not support proper glycemic control of the diabetic patient (Browning & Dumo, 2004); however, basal-bolus insulin administration provides optimal management of hyperglycemia in DM-2 patients (Umpierrez et al., 2007; Umpierrez et al., 2011).”
BackgroundHuri, H. Z., Aziz, M. I. A., Vethakkan, S. R., & Widodo, R. T. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i6.26 · Cited by 5
Arnold, L. M., Mahesri, M., McDonnell, M. E., & Alexanian, S. M. (2016) · Endocrine Practice · doi:10.4158/ep161354.or · Cited by 5
“Umpierrez et al performed a randomized trial comparing basal-bolus insulin vs sliding scale in postoperative surgery patients, and demonstrated a lowering in mean hospital glucose of 157 mg/dL vs 176 mg/dL (18).”
MethodImproving inpatient glycemic control by diabetes education program in internal medicine residents
Sriphrapradang, C., Mongkolrattanakul, P., Tanasanitkul, H., & Reutrakul, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.029 · Cited by 5
Patzek, S. M., MacMaster, H. W., Rov-Ikpah, E., Luis, C. S., Johnson, C., Juttukonda, V., & Rushakoff, R. J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820948132 · Cited by 5
Zhang, X., Zhang, T., Xiang, G., Wang, W., Li, Y., Du, T., Zhao, Y., Mosha, S. S., & Li, W. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001261 · Cited by 5
Elsayed, A. S., Elbadawy, A., Ibrahim, W., sallama, M., & Abdelmoniem, R. O. (2021) · Benha Medical Journal · doi:10.21608/bmfj.2021.49219.1341 · Cited by 5
“Length of stay (days) Median (range) 7 (1-30)”
BackgroundManagement of older hospitalized patients with type 2 diabetes using linagliptin: Lina-Older study
Perez-Belmonte, L. M., Osuna‐Sánchez, J., Ricci, M., Millán‐Gómez, M., Lopez-Carmona, M. D., Barbancho, M. Á., Bernal-López, M. R., Jansen‐Chaparro, S., Lara, J. P., & Gómez‐Huelgas, R. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.21.04085-4 · Cited by 5
Man, K., Lee, Y., Chen, Y., Chen, Y., Chang, S., & Huang, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5852599 · Cited by 6
“Existing evidence indicates that correction of hyperglycemia with insulin therapy reduces hospital complications and decreases mortality in cardiac [6] and general surgery [7] patients.”
BackgroundPark, J., Kim, E., Lee, J., Chung, S. H., Boo, G., & Do, S.-H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113040 · Cited by 5
“Strictly controlled perioperative blood glucose management using long-acting insulin and short-acting insulin confirmed a superior postoperative glucose profile than sliding scale insulin [39].”
BackgroundControl hospitalario de la diabetes y de la hiperglucemia: una auditoría en hospitales españoles
Ena, J., Carretero‐Gómez, J., Rojo, J. M. C., Casado, P., Vázquez-Rodríguez, P., Martínez-García, F., González-González, P., de Escalante-Yangüela, B., Gandullo-Moro, M., & Carrasco-Sánchez, F. J. (2023) · Revista Clínica Española · doi:10.1016/j.rce.2023.04.002 · Cited by 7
Jacovides, C. L., Skeete, D. A., Werner, N. L., Toschlog, E. A., Agarwal, S., Coopwood, B., Crandall, M. L., & Tominaga, G. T. (2023) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000004124 · Cited by 5
“35 To determine the appropriate regimen, calculate the total daily dose of insulin (TDD) by multiplying the prior 6 hours of insulin administration by four to estimate the patient's 24-hour insulin requirement.”
MethodJackson, B., & Grubbs, L. M. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12033 · Cited by 5
“Umpierrez et al. (2007) compared a basal-bolus insulin regimen with that of sliding scale regular insulin (SSI) in medical patients with type 2 DM and reported only two patients in each treatment group experienced hypoglycemia (≤60 mg/dL).”
BackgroundMethodResultInfluentialEvidence for Basal–Bolus Insulin Versus Slide Scale Insulin
Badlani, S., Ford, W. T., Yu, D. J., Brogan, G. X., Pollack, C. V., & Volturo, G. (2014) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-013-0032-4 · Cited by 5
Cuervo, C. G., Morla, A. S., Asín, M. A. P., Pardo, O. B., Ordoño, L. P., & Santos, J. V. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2015.11.008 · Cited by 6
“Umpierrez, 201317 BB 156(36); BC 163 (37) 172 (41)* BB 5,9 (5), BC 6,0 (6) 5,5 (5) Gosmanov, 201325 176,8 (35) 298 (71,4)* 19,7 (16,2) 19,7 (13,7) Roberts, 201226 56%** 50%*,** Mediana (RIQ) 13 (7-23) Mediana (RIQ): 13 (7-22) Deno, 201127 137,6 (42,7) 208,4 (82,2)* 3,2 (1,7) 3,9 (3) Umpierrez, 201116 157 (32) 176 (44)…”
Stress ulcer prophylaxis (January 2014)
Chongnarungsin, D. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81c.06004 · Cited by 5
In Reply: Stress ulcer prophylaxis (January 2014)
Bazerbachi, F., Eisa, N., Alraiyes, A. H., & Alraies, M. C. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81c.06005 · Cited by 5
In Reply: Insulin before surgery (November 2013)
Dobri, G. A., & Lansang, M. C. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.81c.06002 · Cited by 5
Depczynski, B., Kibret, G. D., Georgiou, A., & Lau, S. M. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089652 · Cited by 4
Perez-Belmonte, L. M., Prieto-Laín, N., Trenas, A., & Gómez-Huelgas, R. (2026) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2026.502491 · Cited by 6
Automated Insulin Delivery Systems in Hospitals: A Systematic Review with Meta-Analysis
Olsen, M. T., Liarakos, A. L., Wilmot, E. G., Dhatariya, K., Mustafa, O. G., Thabit, H., Kristensen, P. L., Andersen, T. H., Klopf, P., Nørgaard, K., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261457746 · Cited by 4
“46 The landmark RABBIT trial 47,48 demonstrated that basal – bolus insulin therapy signi fi cantly improved glycemic outcomes and reduced postoperative complications compared with correctional insulin or “ sliding scale insulin ” alone in patients with type 2 diabetes, supporting the adoption of…”
Manejo de la hiperglucemia en el paciente hospitalizado no crítico con alimentación oral
Jansen, S., Buonaiuto, V. A., Márquez-Gómez, I., & Gómez‐Huelgas, R. (2011) · Revista Clínica Española · doi:10.1016/j.rce.2011.05.014 · Cited by 7
Tang, H., Lai, Y., Zhao, E., Zeng, W., Zhou, K., & Zhou, Z. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.07.048 · Cited by 5
Petite, S. E., Huenecke, J., & Tuttle, N. (2019) · Hospital Pharmacy · doi:10.1177/0018578719841029 · Cited by 4
“The overall rate of hypoglycemia observed in this study was similar to rates reported in previous trials.(8,9) The study population was similar to the Basal-Plus trial, evaluating a combined non-ICU and surgical cohort.”
BackgroundResultEvaluation of Dipeptidyl Peptidase-IV Inhibitor Use in Hospitalized Patients With Diabetes
Petite, S. E., & Hill, M. C. (2021) · Annals of Pharmacotherapy · doi:10.1177/1060028021996337 · Cited by 4
“There was a significant difference in hospital LOS (5 [interquartile range = 3-8] vs 6 [4-11] days; P = 0.”
BackgroundBanks, C. A., Novak, Z., Beck, A. W., Pearce, B. J., Patterson, M. A., Passman, M. A., Sutzko, D. C., Tariq, M., Morgan, M., & Spangler, E. L. (2023) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2023.04.027 · Cited by 5
Meyrat, R. B., Vivian, E., Sridhar, A., Gulden, R. H., Bruce, S., Martinez, A., Montgomery, L. G., Reed, D. N., Rappa, P. J., Makanbhai, H., et al. (2023) · Medicine · doi:10.1097/md.0000000000036142 · Cited by 6
Enhancing Perioperative Diabetes Care: Strategies and Challenges
Rayman, G. A. (2024) · Diabetes Care · doi:10.2337/dci24-0010 · Cited by 4
Garzón, E. M., Montoya, A. G., & Herrera, G. H. (2024) · Journal of Diabetes Research · doi:10.1155/2024/3451158 · Cited by 4
“However, this leads to signi fi cant variability in the records reported and published across di ff erent studies, with daily glucose tests generally ranging from about three, as observed in the RABBIT 2 Surgery study [29], to between 2 and 4 measurements per day [5, 12, 19 – 21, 23 ].”
MethodInsulin delivery devices in diabetes management: Applications and advancements
Yang, R., Yang, Z., Chi, J., & Ya, Z. (2025) · Intelligent Pharmacy · doi:10.1016/j.ipha.2025.02.002 · Cited by 8
Capitanu, B.-S., Mihăilescu, A.-A., Grădinaru, S., Kraft, A., Blendea, C.-D., & Neagu, Ş. I. (2025) · Journal of Medicine and Life · doi:10.25122/jml-2025-0049 · Cited by 4
A toolbox to improve algorithms for insulin-dosing decision support
Donsa, K., Plank, J., Schaupp, L., Mader, J. K., Truskaller, T., Tschapeller, B., Höll, B., Spat, S., Pieber, T. R., & Beck, P. (2014) · Applied Clinical Informatics · doi:10.4338/aci-2014-04-ra-0033 · Cited by 4
“Observational and randomized controlled studies indicate that when glycemic control improves, hospital complication rates are lowered in general medical and surgery patients [3–7].”
BackgroundIn-Silico Trials for Glucose Control in Hospitalized Patients with Type 2 Diabetes
Choi, K., Oh, T. J., Lee, J. C., Kim, M.-J., Kim, H. C., Cho, Y. M., & Kim, S. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.2.231 · Cited by 5
“From Equations (3) and (7), the total subcutaneous insulin absorption rate (Isc) can be written as: Isc = cf ·(Isc1 + Isc2) (8)”
BackgroundMethodResultInfluentialAn Interdepartmental Collaboration to Improve Preoperative Glycemic Control
LaBoone, L. M., McLarney, J. T., & Reynolds, L. R. (2014) · Hospital Practice · doi:10.3810/hp.2014.12.1161 · Cited by 4
Thomann, R., Schüetz, P., Müller, B., Thomke, S., Schoenenberger, R. A., & Keller, U. B. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13808 · Cited by 4
Shacham, E. C., Nitzan, R., Schwartz, N., & Ishay, A. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.09.009 · Cited by 4
Soto-Chávez, M. J., Múñoz, Ó., Álzate, J. P., Moreno, C. E. L., Henao, D. C., & Medina, A. M. G. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110019 · Cited by 4
Kemeç, Z., & Akgül, F. (2022) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_290_22 · Cited by 4
Yago, G., Venturas, M., Blanco, J., Pérez, I., Falces, C., Roqué, M., Yugueros, X., Cardete, L., Renú, A., Caellas, D., et al. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.07.008 · Cited by 4
A Pharmacist-Led Practice to Improve Perioperative Glycemic Control in Elective Surgery
Morin, N. P. (2023) · Clinical Diabetes · doi:10.2337/cd21-0139 · Cited by 4
Kinio, A. E., Gold, M. S., Doonan, R. J., Steinmetz, O. K., MacKenzie, K. S., Obrand, D. I., Girsowicz, E., Bayne, J. P., & Gill, H. L. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2023.03.009 · Cited by 4
Role of Subcutaneous Insulin Management Protocols and Order Sets in Inpatient Diabetes Management
Houlden, R. L., Moore, S., Cornish, W., & Tiwana, K. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.02.001 · Cited by 4
Comparative efficacy and safety of insulin analogs in hospitalized adults
Singh, K., Ansari, M., Patel, R. V., Bédard, M., Keely, E., Tierney, M., & Moher, D. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140161 · Cited by 4
Oliveira, R. A., Poveda, V. D. B., & Tanner, J. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13390 · Cited by 4
“Allograft rejection follow-up: mean 1 y 24 per 100 21 per 100 (12-37) RR 0.”
BackgroundIn-hospital Management of Diabetes
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.015 · Cited by 4
Khan, S. A., Demidowich, A. P., Tschudy, M. M., Wedler, J., Lamy, W., Akpandak, I., Alexander, L. A., Misra, I., Sidhaye, A., Rotello, L., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231153883 · Cited by 3
Farnham, C., Liu, I. Z., Agarwal, A. R., Parel, P. M., Quan, T., Durand, W. M., Raad, M., & Jain, A. (2025) · Global Spine Journal · doi:10.1177/21925682251315098 · Cited by 3
“Further review of prior literature yields that preoperative hyperglycemia outside of the realm of spinal surgery increases the risk for pulmonary embolism, 27 morbidity, 28 mortality, 29 pneumonia, 30 renal failure, 30 and SSIs.”
Couteur, J. L., Druce, P., Myles, P. S., & Peel, T. N. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005438 · Cited by 4
Wang, R., Kyi, M., Krishnamoorthi, B., Connell, A., Chiang, C. Y., Renouf, D., Barmanray, R., & Fourlanos, S. (2025) · Diabetic Medicine · doi:10.1111/dme.70076 · Cited by 3
Olsen, M. T., Hjejle, S., Rasmussen, L. M., Klarskov, C. K., Lindegaard, B., Andersen, J. A., Gottlieb, H., Lunding, S., Nørgaard, K., Pedersen‐Bjergaard, U., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf137 · Cited by 3
Marino, E. C., Negretto, L. A. F., Ribeiro, R. S., Momesso, D., Feitosa, A. C. R., Toyoshima, M. T. K., da Silva, J. C., Vencio, S. A. C., Lauria, M. W., de Sá, J. R., et al. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02060-5 · Cited by 3
Rapid-acting insulin glulisine: an update on clinical experience
DAILEY, G. E. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.40 · Cited by 4
Cook, C. B., Apsey, H. A., Habermann, E. B., Glasgow, A. E., Castro, J. C., & Schlinkert, R. T. (2017) · Endocrine Practice · doi:10.4158/ep161621.co · Cited by 3
Piatti, P., Cioni, M., Magistro, A., Villa, V., Crippa, V. G., Galluccio, E., Fontana, B., Spadoni, S., Bosi, E., Monti, L. D., et al. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.01.005 · Cited by 3
Use of Insulin in the Inpatient Setting: Need for Continued Use
Kumar, S., & Molitch, M. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1183-9 · Cited by 3
Kurisu, K., Tsurutani, Y., Inoue, K., Hoshino, Y., Saiki, F., & Yoshiuchi, K. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13210 · Cited by 4
Tran, M. N. T., Dang, K. T., Lý, Đ. L., & Tran, N. Q. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01079-y · Cited by 3
“This combination regimen results in better BG levels [6–8], lower frequency of hypoglycemic events [9], and fewer hospital complications [7] than other insulin regimens.”
BackgroundKoshizaka, M., Ishibashi, R., Maeda, Y., Ishikawa, T., Maezawa, Y., Takemoto, M., & Yokote, K. (2022) · Diabetology International · doi:10.1007/s13340-022-00587-w · Cited by 3
“In high-risk patients, suppressing hyperglycemia and blood glucose fluctuations could reduce complications [21] and may lead to the prevention of SSI, and potentially reduce the duration of hospitalization and extra medical costs.”
BackgroundThe Role of the Health Care Professions in Preventing Surgical Site Infection
Spratt, D. G., Dutton, R. P., Dellinger, E. P., Bird, B. L., Guglielmi, C. L., Farber, M. R., & Groah, L. K. (2012) · AORN Journal · doi:10.1016/j.aorn.2012.01.024 · Cited by 3
Moghissi, E. S., Inzucchi, S. E., Mann, K. V., Byerly, B., Ermentrout, L., Juchniewicz, J. J., Ferareza, J. H., & Kirkwood, N. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1103191 · Cited by 3
“general surgery have been demonstrated, with postoperative complications (including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure) reduced through the use of basal bolus insulin therapy.[19] The”
BackgroundDurán, S., Rivas, M. A. P., & Pérez, A. (2016) · Cited by 3
Co-Managing Patients with Type 1 Diabetes and Cancer
Best, C. J., Thosani, S., Ortiz, M. R., Levesque, C. A., Varghese, S. S., & Lavis, V. R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0766-y · Cited by 5
Management of Hyperglycemia in Hospitalized Noncritical Patients
Mikhail, N. E. (2013) · Southern Medical Journal · doi:10.1097/smj.0b013e318287febe · Cited by 3
“7%).(19) Thus, the use of the sliding scale as the sole method of controlling BG in hospitals is strongly discouraged except in patients with mild, infrequent hyperglycemia (most BG G180 mg/dL) and non-diabetic patients starting high-dose glucocorticoids.”
MethodDiabetes Mellitus and Peripheral Vascular Disease
Freeby, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_3 · Cited by 3
Glycemic Control in Cancer Patients
Lee, K. A., Baek, H. S., & Park, T. S. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.3.168 · Cited by 3
“과거에 사용된 차등제 인슐린투여 (sliding-scale insulin) 요법은 혈당조절에 효과적이지 못하 고, 저혈당 부작용을 높이는 결과가 보고되어 추천되지 않 는다[23].”
Mamillapalli, C. K., Rico, E., Nallala, D., Mansuri, O., & Jakoby, M. (2018) · Cureus · doi:10.7759/cureus.2879 · Cited by 3
Leighton, M. E., Thompson, B., Castro, J. C., & Cook, C. B. (2020) · Applied Nursing Research · doi:10.1016/j.apnr.2020.151338 · Cited by 3
Atkinson, B., Corl, D. E., Pergamit, R. F., Weaver, K. W., Tylee, T. S., & Wisse, B. E. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.11.007 · Cited by 3
Moon, S. J., Choe, H. J., Kwak, S. H., Jung, H. S., Park, K. S., & Cho, Y. M. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0065 · Cited by 4
“In-hospital hyperglycemia is associated with increased morbidity and mortality in critically ill patients admitted to the intensive care unit; however, it has also proven to be an independent risk factor for morbidity and mortality in patients admitted to surgery or general medicine wards [5,6].”
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., & Madrigal‐Santillán, E. (2021) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2021.09.003 · Cited by 3
Kuchay, M. S., Mathew, A., Mishra, M., Surendran, P., Kaur, P., Wasir, J. S., Gill, H. K., Jain, R., Gagneja, S., Kohli, C., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.15002 · Cited by 3
Priya, V., Bais, P. S., Rastogi, A., Shamim, R., Aggarwal, A., & Patro, A. (2023) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_463_21 · Cited by 3
“[20,21] Despite lack of scrutiny, the mainstay of peri‑operative metabolic control in diabetics has been the administration of IV glucose with potassium chloride and an insulin infusion.”
BackgroundIn‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., Newland‐Jones, P., & Patel, M. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch39 · Cited by 3
Management of Hyperglycemia in Hospitalized Patients: Noncritical Care Setting
Pichardo-Lowden, A. R. (2014) · Frontiers in diabetes · doi:10.1159/000363468 · Cited by 4
Huang, Q., Lou, F., Ping, W. A. N. G., Liu, Q., Wang, K., ZHANG, L., Lei, Z. H. U., Yu, S. L., Xu, H., Wang, Q., et al. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130611 · Cited by 3
“More and more diabetic patients face on the problem of surgery.(2) In many aspects, diabetes greatly influence to surgical prognosis.”
BackgroundHarbin, M., Dossa, A., de Lemos, J., Drummond, I., Paty, B. W., & Taylor, B. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.10.004 · Cited by 3
Martínez‐Brocca, M. A., Morales, C., Rodríguez-Ortega, P., González-Aguilera, B., Montes, C., Colomo, N., Piédrola, G., Méndez-Muros, M., Serrano, I., de Adana, M. S. R., et al. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.02.002 · Cited by 4
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.